Short Pulse and Q-switched ND-YAG Laser With Topical Carbon Versus Fractional CO2 Laser for Enlarged Facial Pores
NCT ID: NCT04470466
Last Updated: 2020-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2020-07-19
2020-10-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims at the assessment and comparison of therapy with short pulsed and Q-switched Nd-YAG laser plus topical carbon with fractional CO2 laser in the management of wide facial pores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of 1565-nm Non-ablative Fractional Laser Versus Long-pulsed 1064-nm Nd:YAG Laser in the Treatment of Enlarged Facial Pores
NCT05360043
Fractional Co2 Laser Versus Microbotox Injection in the Treatment of Wide Facial Pores: A Split Face Comparative Study
NCT05923996
Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores
NCT06293755
A Study of the Efficacy of Erbium:YAG 2940nm in Combination With 1064nm Laser on Facial Rejuvenation
NCT03962621
The Safety and Efficacy of 1064-nm Picosecond Laser With Microlens Array for Pore Tightening; a Pilot Study
NCT04471948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
fractional CO2 laser will be performed to the other half of the face. the patients will receive 2 treatment sessions
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
short pulse and Q-switched ND-YAG laser with topical carbon
short pulse and Q-switched ND-YAG laser with topical carbon
application of topical carbon cream, followed by two passes of short pulse 1064 ND-YAG, then one pass of Q-switched 1064 ND-YAG on one side of the face
Fractional CO2 Laser
fractional CO2 laser
single pass of fractional CO2 laser on the other side of the face
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
short pulse and Q-switched ND-YAG laser with topical carbon
application of topical carbon cream, followed by two passes of short pulse 1064 ND-YAG, then one pass of Q-switched 1064 ND-YAG on one side of the face
fractional CO2 laser
single pass of fractional CO2 laser on the other side of the face
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with any contraindication to laser therapy such as photosensitive diseases, skin malignancies, patients on oral retinoids.
* Keloid-forming tendency.
* Local or systemic treatment for skin pores in the previous 3 months
* Connective tissue disease or the use of immunosuppressive medications.
* Pregnancy.
* Present or past history of herpes labialis.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina Saadi
principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr Alainy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
las49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.